Zhuang Linghang, Wai John S, Embrey Mark W, Fisher Thorsten E, Egbertson Melissa S, Payne Linda S, Guare James P, Vacca Joseph P, Hazuda Daria J, Felock Peter J, Wolfe Abigail L, Stillmock Kara A, Witmer Marc V, Moyer Gregory, Schleif William A, Gabryelski Lori J, Leonard Yvonne M, Lynch Joseph J, Michelson Stuart R, Young Steven D
Departments of Medicinal Chemistry, Antiviral Research, and Pharmacology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
J Med Chem. 2003 Feb 13;46(4):453-6. doi: 10.1021/jm025553u.
Naphthyridine 7 inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 microM. It does not exhibit cytotoxicity in cell culture at < or =12.5 microM and shows a good pharmacokinetic profile when dosed orally to rats. The antiviral activity of 7 and its effect on integration were confirmed using viruses with specific integrase mutations.
萘啶 7 抑制整合酶催化的整合过程中的链转移,IC50 为 10 nM,在 0.39 microM 时可抑制细胞培养中 95% 的 HIV-1 感染传播。在细胞培养中,当浓度≤12.5 microM 时,它不表现出细胞毒性,口服给药至大鼠时显示出良好的药代动力学特征。使用具有特定整合酶突变的病毒证实了 7 的抗病毒活性及其对整合的影响。